Icagen, Inc. has appointed Seth Hetherington, M.D. to the position of senior vice president, clinical and regulatory affairs. Dr. Hetherington is an experienced drug development executive, with more than 25 years of experience in clinical drug development and academic medicine. Most recently, Dr. Hetherington served as vice president, clinical development and chief medical officer at Inhibitex, Inc. from 2002 to May 2006. From 1995 to 2002, Dr. Hetherington served in positions of increasin...